Skip to main content
. 2022 Aug 16;20:276. doi: 10.1186/s12916-022-02451-9

Fig. 2.

Fig. 2

Central illustration: Changes from baseline to follow-up by treatment arm in (A): Flow mediated dilation (%FMD); (B): Peak cutaneous vascular conductance responses to acetylcholine (ACh); (C):Peak cutaneous vascular conductance responses to sodium nitroprusside (SNP); (D): Mean arterial pressure (MAP)